(RTTNews) - Shares of bioAffinity Technologies Inc. (BIAF) are up over 10% in Wednesday's trading, after the company announced stronger-than-expected unit growth in the first quarter of 2026 for its noninvasive diagnostic test, CyPath Lung.
1 views
BioAffinity Soars On Strong Preliminary Sales Growth Of CyPath Lung Test
(RTTNews) - Shares of bioAffinity Technologies Inc. (BIAF) are up over 10% in Wednesday's trading, after the company announced stronger-than-expected unit growth in the first quarter of 2026 for its noninvasive…
